Common Cold Antibodies May Hinder Defense Against SARS-CoV-2
Antibodies to common-cold viruses, collectively known as hCoV, may hamper the body's response to SARS-CoV-2, according to new data. Earlier studies have disagreed on whether previously acquired hCoV antibodies protect against SARS-CoV-2 infection.
Reuters Health Information
source https://www.medscape.com/viewarticle/964683?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/964683?src=rss
Comments
Post a Comment